GN0M.DE vs. 2B70.DE
Compare and contrast key facts about Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE).
GN0M.DE and 2B70.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. GN0M.DE is a passively managed fund by Global X that tracks the performance of the Solactive Genomics. It was launched on Nov 2, 2021. 2B70.DE is a passively managed fund by iShares that tracks the performance of the Nasdaq Biotechnology. It was launched on Oct 19, 2017. Both GN0M.DE and 2B70.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
GN0M.DE vs. 2B70.DE - Performance Comparison
Loading graphics...
GN0M.DE vs. 2B70.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | -1.12% | 5.67% | -12.40% | -9.04% | -32.50% | -7.90% |
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 2.97% | 18.62% | 4.60% | 2.56% | -6.29% | -0.79% |
Returns By Period
In the year-to-date period, GN0M.DE achieves a -1.12% return, which is significantly lower than 2B70.DE's 2.97% return.
GN0M.DE
- 1D
- 3.50%
- 1M
- -3.99%
- YTD
- -1.12%
- 6M
- 14.80%
- 1Y
- 31.77%
- 3Y*
- -4.51%
- 5Y*
- —
- 10Y*
- —
2B70.DE
- 1D
- -0.65%
- 1M
- 0.03%
- YTD
- 2.97%
- 6M
- 18.25%
- 1Y
- 30.77%
- 3Y*
- 10.42%
- 5Y*
- 4.82%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
GN0M.DE vs. 2B70.DE - Expense Ratio Comparison
GN0M.DE has a 0.50% expense ratio, which is higher than 2B70.DE's 0.35% expense ratio.
Return for Risk
GN0M.DE vs. 2B70.DE — Risk / Return Rank
GN0M.DE
2B70.DE
GN0M.DE vs. 2B70.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GN0M.DE | 2B70.DE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.03 | 1.37 | -0.34 |
Sortino ratioReturn per unit of downside risk | 1.55 | 1.89 | -0.34 |
Omega ratioGain probability vs. loss probability | 1.19 | 1.25 | -0.06 |
Calmar ratioReturn relative to maximum drawdown | 1.97 | 3.61 | -1.64 |
Martin ratioReturn relative to average drawdown | 5.80 | 13.43 | -7.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GN0M.DE | 2B70.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.03 | 1.37 | -0.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.23 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.44 | 0.36 | -0.79 |
Correlation
The correlation between GN0M.DE and 2B70.DE is 0.82, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
GN0M.DE vs. 2B70.DE - Dividend Comparison
Neither GN0M.DE nor 2B70.DE has paid dividends to shareholders.
Drawdowns
GN0M.DE vs. 2B70.DE - Drawdown Comparison
The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than 2B70.DE's maximum drawdown of -30.87%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and 2B70.DE.
Loading graphics...
Drawdown Indicators
| GN0M.DE | 2B70.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.19% | -30.87% | -36.32% |
Max Drawdown (1Y)Largest decline over 1 year | -16.68% | -12.69% | -3.99% |
Max Drawdown (5Y)Largest decline over 5 years | — | -30.87% | — |
Current DrawdownCurrent decline from peak | -48.40% | -1.71% | -46.69% |
Average DrawdownAverage peak-to-trough decline | -42.98% | -10.16% | -32.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.67% | 2.62% | +3.05% |
Volatility
GN0M.DE vs. 2B70.DE - Volatility Comparison
Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a higher volatility of 9.44% compared to iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) at 6.78%. This indicates that GN0M.DE's price experiences larger fluctuations and is considered to be riskier than 2B70.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| GN0M.DE | 2B70.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.44% | 6.78% | +2.66% |
Volatility (6M)Calculated over the trailing 6-month period | 21.36% | 13.48% | +7.88% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.78% | 22.49% | +8.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.58% | 20.45% | +11.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.58% | 21.78% | +9.80% |